Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Akebia Therapeutics
- 08 Nov 2017 According to an Akebia Therapeutics media release, data from this trial expected by year end.
- 26 Sep 2017 According to an Akebia Therapeutics media release, company in collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC), expects top-line data from this study.
- 28 Jun 2017 Status changed from recruiting to active, no longer recruiting.